Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00596947 · ClinicalTrials.gov registry record · Phase 4
Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant
A Phase 4 study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
NCT00596947: Clinical Trial Phase 4 study, sponsored by University of Pennsylvania.
NCT00596947 is a Phase 4 study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00596947, a Phase 4 study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of the study was to determine if rapid discontinuation of corticosteroids (also known as prednisone withdrawal) and maintenance immunosuppression with Prograf (tacrolimus) and CellCept (mycophenolate mofetil) while using Thymoglobulin (Rabbit antithymocyte globulin) will give similar safety and efficacy results compared to continuation of corticosteroids (also known as prednisone maintenance) and standard maintenance immunosuppression with Prograf (tacrolimus), CellCept (mycophenolate mofetil) while using Thymoglobulin (Rabbit antithymocyte globulin).
Interventions
- DRUG Prednisone
- DRUG prednisone
- DRUG Tacrolimus
- DRUG Mycophenolate mofetil
- DRUG rabbit antithymocyte globulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2005-10 |
| Est. Completion | 2009-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00596947
The ClinicalTrials.gov registry entry for NCT00596947 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Prednisone is the first listed.
NCT00596947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00596947 about?
NCT00596947 is a clinical study titled "Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant". The purpose of the study was to determine if rapid discontinuation of corticosteroids (also known as prednisone withdrawal) and maintenance immunosuppression with Prograf (tacrolimus) and CellCept (mycophenolate mofetil) while using Thymoglobulin (Rabbit antithymocyte globulin) will give similar saf...
What is the current status of trial NCT00596947?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2005-10. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00596947?
The interventions under investigation include: Prednisone (DRUG), prednisone (DRUG), Tacrolimus (DRUG), Mycophenolate mofetil (DRUG), rabbit antithymocyte globulin (DRUG).
Who is sponsoring clinical trial NCT00596947?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.